Aeglea Biotherapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.1M | 425k | 16.76 |
| 2025-06-30 | $6.3M | 419k | 14.97 |
| 2025-03-31 | $6.2M | 383k | 16.14 |
| 2024-12-31 | $8.8M | 380k | 23.28 |
| 2024-09-30 | $9.8M | 333k | 29.41 |
| 2024-06-30 | $2.3M | 98k | 23.51 |
| 2024-03-31 | $569k | 15k | 37.93 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management